Pyxis Oncology, Inc.

NASDAQ:PYXS

Biotechnology

Healthcare
$1.41 +5.53%

+$0.11 today

Market cap
$168.65M
Beta
1.43
P/E (TTM)
-1.6
EPS (TTM)
-$1.29
52W Low $0.97High $5.55

Volume 0.75M

Average 0.50M

Income Statement

Follow revenue through to earnings.

Revenue

$13.86M

FY 2025 · Annual

-14.2% YoY

Operating Income

-$84.42M

FY 2025 · Annual

Net Income

-$79.62M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00016.15M13.86M
Cost of Revenue000475K2.39M
Gross Profit00015.67M11.47M
Gross Margin———97.1%82.8%
Research & Development51.05M86.13M49.59M58.75M73.7M
Selling, General & Admin18.66M37.35M32.61M25.42M22.19M
Operating Expenses69.72M123.48M82.2M105.13M95.89M
Depreciation & Amortization647K709K1.93M2.98M4.51M
EBITDA(75.33M)(120.01M)(71.86M)(65.51M)(73.72M)
EBITDA Margin———-405.8%-532.0%
Operating Income(69.72M)(123.48M)(82.2M)(89.46M)(84.42M)
Operating Margin———-554.1%-609.2%
Interest Income23K2.76M6.63M7.04M3.61M
Interest Expense00000
Other Income / Expenses(6.26M)2.76M8.41M9.97M6.19M
Income Before Tax(75.98M)(120.72M)(73.79M)(79.5M)(78.24M)
Pre-Tax Margin———-492.4%-564.5%
Income Tax Expense000(2.16M)1.39M
Net Income(75.98M)(120.72M)(73.79M)(77.33M)(79.62M)
Net Margin———-478.9%-574.5%
EPS (Basic)(2.53)(3.57)(1.85)(1.32)(1.28)
EPS (Diluted)(2.53)(3.57)(1.85)(1.32)(1.28)
Weighted Avg Shares32.22M33.03M39.9M58.45M62.14M
Weighted Avg Shares (Diluted)32.22M33.03M39.9M58.45M62.14M

PYXS Earnings Waterfall · TTM

NASDAQ:PYXS · Revenue to Net Income

Key Ratios

EPS$-1.31
Gross Margin51.0%
Net Margin-203.7%
P/E Ratio-1.1
P/S Ratio7.7

Analysis

$13.9M of revenue converted into -$81.7M of net income for the selected period. Gross margin is 51.0% and net margin is -203.7%, showing how much revenue survives after costs and taxes. EPS is $-1.31, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
4Statement of changes in beneficial ownershipNov 6, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 3, 2026

How much revenue does PYXS generate?

Pyxis Oncology, Inc. (PYXS) reported $13.86M of revenue in fiscal 2025.

Is PYXS profitable?

Pyxis Oncology, Inc. (PYXS) reported -$79.62M of net income, with a net margin of -574.5%.